Pietrantonio, F., Maggi, C., Di Bartolomeo, M., Facciorusso, M. G., Perrone, F., Testi, A., . . . de Braud, F. (2014). Gain of ALK Gene Copy Number May Predict Lack of Benefit from Anti-EGFR Treatment in Patients with Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status. Public Library of Science.
Citação norma ChicagoPietrantonio, Filippo, et al. Gain of ALK Gene Copy Number May Predict Lack of Benefit From Anti-EGFR Treatment in Patients With Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status. Public Library of Science, 2014.
MLA citiranjePietrantonio, Filippo, et al. Gain of ALK Gene Copy Number May Predict Lack of Benefit From Anti-EGFR Treatment in Patients With Advanced Colorectal Cancer and RAS-RAF-PI3KCA Wild-Type Status. Public Library of Science, 2014.